FREE Shipping on all US Orders
There is a second active compound in green tea that has nothing to do with antioxidants. A 2025 review just took it seriously.
A 2025 systematic review covering 684 participants across 9 clinical trials found that topical caffeine consistently demonstrated hair growth or reduced hair loss with minimal adverse effects. The mechanism — selective non-inhibition of 5-alpha reductase, phosphodiesterase inhibition, increased cAMP, and direct antioxidant activity — is distinct from anything covered in this series. Green tea, already in the Laritelle formula for EGCG, also delivers caffeine. Here is the other half of what it does.
Caffeine penetrates well into human skin — it is a model substance for skin barrier penetration studies. It has been extensively studied and proven to have good penetration and bioavailability after topical application on the scalp. The compound most associated with morning alertness turns out to have one of the best-documented delivery profiles of any topical hair active.
Green tea has appeared throughout this series as an antioxidant — EGCG protecting collagen from oxidative degradation, supporting HIF-1α signalling integrity, reducing the sebum oxidation that feeds PIILIF inflammation. All of that is accurate and well-supported. It is also half the story.
Green tea also contains caffeine — and a 2025 systematic review took the question of what topical caffeine does for hair seriously enough to screen 1,121 articles down to 9 qualifying clinical trials covering 684 participants with androgenetic alopecia, excessive hair loss, or hair thinning. Topical caffeine consistently demonstrated hair growth or reduced hair loss with minimal adverse effects across the trials reviewed. The authors concluded that caffeine appears to be a safe and promising potential treatment for hair loss, while noting that further large-scale randomised controlled trials with standardised outcome measures are needed.
The mechanism through which caffeine operates is genuinely distinct from every other botanical compound covered in this series — and it adds a dimension to the green tea component of the formula that the EGCG/antioxidant framing alone doesn't capture.
The Mechanism
How caffeine reaches the follicle — through a pathway nothing else uses.
This is a careful and unusual phrase — "selective non-inhibition" — and it describes something specific. Finasteride works by blocking 5-alpha reductase entirely, which is why it has systemic hormonal side effects. Caffeine appears to interact with the enzyme system differently — not blocking it the way finasteride does, but modulating follicle metabolism through a separate pathway that doesn't carry the same systemic hormonal consequences.
This is mechanistically distinct from bhringaraj, nettle, and saw palmetto — all of which work through actual 5-alpha reductase inhibition, the same category as finasteride but topical and botanical. Caffeine is doing something else entirely — which means it is not redundant with the DHT-inhibiting botanicals already in the formula. It is operating on a parallel track.
Caffeine inhibits phosphodiesterase enzymes, which normally break down cyclic AMP (cAMP) — a secondary messenger molecule inside cells that regulates metabolic activity. By inhibiting the enzyme that degrades cAMP, caffeine increases intracellular cAMP levels, which stimulates metabolic activity in hair follicle cells.
This connects to the energy metabolism thread running through this series — PP405 targets the mitochondrial pyruvate carrier, HIF-1α governs the metabolic shift under low oxygen, and now caffeine is shown to stimulate follicle metabolic activity through a third, independent pathway. Three different mechanisms — pharmaceutical (PP405), oxygen-sensing (HIF-1α), and now a topical botanical compound (caffeine) — all converge on the same broad target: follicle cellular energy and metabolic activity. This is not coincidence. It reflects how central follicle metabolism is to the growth cycle.
Caffeine also acts as an antioxidant and may prevent degenerative processes — through a mechanism independent of EGCG, the polyphenol most associated with green tea's antioxidant reputation. This means green tea is delivering two separate antioxidant mechanisms simultaneously — EGCG's polyphenol antioxidant activity, and caffeine's distinct antioxidant pathway — alongside caffeine's metabolic and 5-alpha reductase effects. A single botanical ingredient, multiple independent mechanisms.
A 2025 study in the International Journal of Cosmetic Science examined the effects of caffeine and adenosine on the scalp microbiome and lipidome. At 12 weeks, anti-hair-loss effects were evident with decreased Pseudomonas, Escherichia-Shigella, and Malassezia, and increased Talaromyces and Cutibacterium — alongside changes in scalp lipid composition.
This is the first time caffeine has been connected to the microbiome research this series covered extensively in May — the MiSCH index, the relationship between Cutibacterium populations and AGA severity, the Malassezia overgrowth associated with PIILIF inflammation. A reduction in Malassezia and an increase in protective Cutibacterium from topical caffeine application is a microbiome-level effect that the EGCG framing of green tea never captured.
The Honest Caveats
What the evidence does and doesn't establish.
The 2025 systematic review is appropriately cautious. None of the studies used tattooed or marked scalp areas for standardised hair counts — a methodological limitation that affects precision across the field, not just caffeine research specifically. Clinical research on caffeine-based therapies remains limited compared to FDA-approved treatments such as topical minoxidil, oral finasteride, and JAK inhibitors. The authors explicitly call for further large-scale randomised controlled trials with standardised outcome measures.
This is not a claim that caffeine is equivalent to minoxidil or finasteride, or that it should replace either. It is a claim that the evidence for topical caffeine — modest in scale but consistent in direction across 684 participants and multiple trial designs — supports its inclusion as a complementary compound, working through mechanisms (cAMP, phosphodiesterase, selective 5-AR non-inhibition, microbiome modulation) that are distinct from the primary actives this series has covered.
A formula built around a single mechanism — even a well-validated one — addresses one pathway. The combination research we covered in May confirmed that combining mechanisms produces synergistic, not merely additive, effects. Green tea's dual delivery — EGCG's antioxidant action and caffeine's metabolic, 5-AR-modulating, and microbiome effects — means a single ingredient is contributing to multiple mechanism categories simultaneously, alongside the DHT-inhibiting botanicals (bhringaraj, nettle), the circulatory botanicals (rosemary, ginger), and the anti-inflammatory botanicals (lavender, patchouli, clove).
Concentration still matters. The clinical trials reviewed used topical caffeine at specific concentrations — typically in the range used in leave-on formulations rather than rinse-off products with short contact time. The 90-second shampoo dwell time covered earlier this month is directly relevant here: a caffeine-containing product rinsed off in 10 seconds is not delivering the same exposure as the formulations tested in the clinical trials.
What this adds to the green tea story.
Green tea has been a consistent presence in this series — protecting collagen, supporting HIF-1α signalling, reducing sebum oxidation. All of that remains true. What the 2025 caffeine research adds is a second, independent mechanism category operating through the same ingredient: metabolic stimulation via cAMP, a distinct antioxidant pathway, selective 5-AR non-inhibition, and microbiome modulation toward the protective Cutibacterium-dominant state that the MiSCH research associated with healthier scalps.
This is the pattern that has recurred throughout this series — a botanical ingredient chosen for one documented mechanism turns out, as research accumulates, to be operating through several. The green tea in the formula was never just an antioxidant. The 2025 research has simply caught up to describing the rest of what it does.
The research keeps finding more of them.
Green tea — delivering more than the antioxidant story alone.
EGCG for collagen and oxidative protection. Caffeine for metabolic stimulation, selective 5-AR modulation, and microbiome support. One botanical, multiple documented mechanisms, applied daily.
→ Explore the Fertile Roots CollectionScience, ritual, and botanical intelligence — delivered daily.
Each morning, one article. New research, ancient wisdom, and the honest science of hair and scalp health. Written for women who want to understand what is happening — not just what to buy.
By subscribing you agree to receive email from Laritelle Organic. Unsubscribe at any time.